Abstract
The aim of this study was to estimate effects of some chemotherapy drugs on the elasticity and deformability of the membrane of a red blood cell (RBC). It was found that incubation of red blood cells (RBCs) with cisplatin or epoetin alpha led to considerable (by 10–17%; p < 0.05) increase in the RBC deformability and that cisplatin could activate tyrosine protein kinases (TPKs). Preincubation of RBCs with a specific inhibitor of EGF-R and Src kinase, lavendustin A, almost completely prevented the cisplatin effect. Tyrosine phosphatase inhibitor, sodium orthovanadate, increased the RBC deformability (p < 0.05). This effect was also abandoned by lavendustin A. To test a hypothesis on the involvement of protein kinases of mature RBCs in control of their membrane elasticity, the cells were incubated with phorbol 12-myristate 13-acetate (PMA) activating protein kinase Cα (PKCα). PMA increased the RBC deformability only moderately (by 8%, p < 0.05) and the effect was canceled by nonselective and selective PKC inhibitors staurosporin and 4-(1-methylindol-3-yl)maleimide hydrochloride. Erythropoietin is known to inhibit the nonselective cation channels of the RBC membrane; however, preincubation of the cells with verapamil did not cancel the increase in their deformability. Hence, this increase in deformability could be a result of the action of tyrosine protein kinases, the more so that this effect was almost completely canceled by lavendustion A. The results suggest that the presence of functionally active protein kinases and phosphatases in the membranes of mature RBC makes them a target for the addressed effects of signal molecules, including some chemotherapy drugs, causing consecutive alterations in the RBC membrane elasticity, microrheological properties, and transport potential.
Similar content being viewed by others
References
Caro C.G., Pedley T.J., Schroter R.C., Seed W.A. 1981. The mechanics of the circulation. M.: Mir.
Baskurt O.K., Meiselman H.J. 2003. Blood rheology and hemodynamics. Semin. Thromb. Hemost. 29, 435–450.
Priers A.R., Secomb T. 2003. Rheology of the microcirculation. Clin. Hemorheol. Microcirc. 29, 143–148.
Reglin B., Secomb T.W., Pries A.R. 2009. Structural adaptation of microvessel diameters in response to metabolic stimuli: where are the oxygen sensors? Amer. J. Physiol. Heart. 297, H2206–H2219.
Oonishi T., Sakashita K., Uysaka N. 1997. Regulation of red blood cell filterability by Ca2+ influx and cAMPmediated signaling pathways. Am. J. Physiol. 273, 1828–1834.
Muravyov A.V., Yakusevich V.V., Maimistova A.A., Chuchkanov F.A., Bulaeva S.V. 2007. Hemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: In vitro study. Clin. Hemorheol. Microcirc. 24, 19–23.
De Oliveira S., Silva-Herdade A., Saldanha C. 2008. Modulation of erythrocyte deformability by PKC activity. Clin. Hemorheol. Microcirc. 39, 363–373.
Muravyov A.V., Tikhomirova I.A. 2013. Role molecular signaling pathways in changes of red blood cell deformability. Clin. Hemorheol. Microcirc. 53 (1–2), 45–59.
Minetti G., Ciana A., Balduini C. 2004. Differential sorting of tyrosine kinases and phosphotyrosine phosphatases acting on band 3 during vesiculation of human erythrocytes. Biochem. J. 377, 489–497.
Sundquist J., Bias S., Hogan J., Faith B., Davis P. 1999. The a1-adrenergic receptor in human erythrocyte membranes mediates interaction in vitro of epinephrine and thyroid hormone at the membrane Ca2+-ATPase. Cellular Signalling. 24, 795–799.
Romero P.J., Romero E.A. 2003. New vanadateinduced Ca2+ pathway in human red cells. Cell Biol. Int. 27, 903–912.
Nunomura W., Takakuwa Y. 2006. Regulation of protein 4.1R interactions with membrane proteins by Ca2+ and calmodulin. Front. Biosci. 11, 1522–1539.
Muravyov A.V., Tikhomirova I.A. 2015. Red blood cell microrheological changes and drug transport efficiency. J. Cell. Biotechnol. 1, 45–51.
Dintenfass L. 1977. Theoretical aspects and clinical applications of the blood viscosity equation containing a term for the internal viscosity of the red cell. Blood Cells. 3, 367–374.
Muravyov A.V., Mikhaylova S.G., Tikhomirova I.A. 2014. Role of the intracellular signaling systems in regulation of erythrocyte microrheology. Biol. membrany (Rus.). 31, 1–7.
Andrews D.A., Yang Lu., Low Ph.S. 2002. Phorbol ester stimulates a protein kinase C-mediated agatoxin-TK-sensitive calcium permeability pathway in human red blood cells. Blood. 100, 3392–3399.
Manno S., Takakuwa Y., Mohandas N. 2005. Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation. J. Biol. Chem. 280, 7581–7587.
Bragadin M., Ion-Popa F., Clari G., Bordin L. 2007. SHP-1 tyrosine phosphatase in human erythrocytes. Ann. N.Y. Acad. Sci. 1095, 193–203.
Mohandas N., Gallagher P.G. 2008. Red cell membrane: Past, present, and future. Blood. 12, 3939–3948.
Mallozzi C., Di Stasi A.M., Minetti M. 1997. Peroxynitrite modulates tyrosine-dependent signal transduction pathway of human erythrocyte band 3. FASEB. 11, 1281–1290.
Govekar R.B., Zingde S.M. 2001. Protein kinase C isoforms in human erythrocytes Ann. Hematol. 80, 531–534.
De Franceschi L., Fumagalli L., Olivieri O., Corrocher R., Lowell C.A., Berton G. 1997. Deficiency of Src family kinases Fgr and Hck results in activation of erythrocyte K/Cl cotransport. J. Clin. Invest. 99 (2), 220–227.
Ingley E. 2012. Functions of the Lyn tyrosine kinase in health and disease. Cell Commun. Signal. 10 (1), 21–32.
Luttrell D.K., Luttrell L.M. 2004. Not so strange bed fellows: G-protein-coupled receptors and Src family kinases. Oncogene. 23 (48), 7969–7978.
Zipser Y., Kosower N.S. 1996. Phosphotyrosine phosphatase associated with band 3 protein in the human erythrocyte membrane. Biochem. J. 314, 881–887.
Pantaleo A., Ferru E., Giribaldi G., Mannu F., Carta F., Matte A., de Franceschi L., Turrini F. 2009. Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-deficient red blood cells. Biochem. J. 418 (2), 359–367.
Hu D.E., Fan T.P. 1995. Suppression of VEGFinduced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A. Br. J. Pharmacol. 114, 262–268.
Kumar R., Shrivastava A., Sodhi A. 1995. Cisplatin stimulates protein tyrosine phosphorylation in macrophages. Biochem. Mol. Biol. Int. 35, 541–547.
Singh R.A., Sodhi A. 1998. Expression and activation of lyn in macrophages treated in vitro with cisplatin: Regulation by kinases, phosphatases and Ca2+/calmodulin. Biochim. Biophys. Acta. 1405, 171–179.
Zipser Y., Piade A., Barbul A., Korenstein R., Kosower N.S. 2002. Ca2+ promotes erythrocyte band 3 tyrosine phosphorylation via dissociation of phosphotyrosine phosphatase from band 3. Biochem. J. 368 (Pt 1), 137–144.
Ling E., Danilov Y.N., Cohen C.M. 1988. Modulation of red cell band 4.1 function by cAMP-dependent kinase and protein kinase C phosphorylation. J. Biol. Chem. 263, 2209–2216.
Silva-Herdade A.S., Freitas T., Almeida J.P., Saldanha C. 2015. Erythrocyte deformability and nitric oxide mobilization under pannexin-1 and PKC dependence. Clin. Hemorheol. Microcirc. 59 (2), 155–162.
Salomao M., Zhang X., Yang Y., Lee S., Hartwig J.H., Chasis J.A., Mohandas N., An X. 2008. Protein 4.1Rdependent multiprotein complex: New insights into the structural organization of the red blood cell membrane. Proc. Natl. Acad. Sci. USA. 105, 8026–8031.
Baciu I., Ivanof L., Pavel T. 1985. Erythropoietin binding to the red cell membranes. Physiologie. 22, 227–231.
Yoshimura A., Arai K. 1996. Physician education: The erythropoietin receptor and signal transduction. Oncologist. 1, 337–339.
De Franceschi L., Fumagalli L., Olivieri O., Corrocher R., Lowell C.A., Berton G. 1997. Deficiency of Src family kinases Fgr and Hck results in activation of erythrocyte K/Cl cotransport. J. Clin. Invest. 99 (2), 220–227.
Avdonin P.V., Tkachuk V.A. 1994. Retseptory i vnutrikletochnyi kaltsii (Receptors and intracellular calcium). M.: Nauka.
Tong W., Zhang J., Lodish H.F. 2005. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood. 15, 4604–4612.
Ruetten H., Thiemermann C. 1997. Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: A possible role for protein tyrosine kinase. Br. J. Pharmacol. 122 (1), 59–70.
Chin H., Arai A., Wakao H., Kamiyama R., Miyasaka N., Miura O. 1998. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood. 91 (10), 3734–3745.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.A. Tikhomirova, A.V. Muravyov, E.P. Petrochenko, N.V. Kislov, S.V. Cheporov, E.V. Peganova, 2016, published in Biologicheskie Membrany, 2016, Vol. 33, No. 1, pp. 62–69.
Rights and permissions
About this article
Cite this article
Tikhomirova, I.A., Muravyov, A.V., Petrochenko, E.P. et al. Alteration of red blood cell microrheology by anti-tumor chemotherapy drugs. Biochem. Moscow Suppl. Ser. A 10, 135–141 (2016). https://doi.org/10.1134/S1990747815050153
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990747815050153